
IN8BIO, INC.
IN8BIO, INC. (INAB)
WebsitePrice
Market cap
Next catalystClinical update at ASH in December 2026; subject to additional capital and changeINB-100 — Phase 1 post-HSCT leukemia trial · Conference presentationSEC filing ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved